Managing Biomarker Testing in NSCLC Patients

Tuesday, November 3, 2020 from 1200-1300 EST

Speakers: Parneet Cheema & Brandon Sheffield

Access the Recording Here

At the end of the session, participants will be able to:

Discuss how care of NSCLC patients has changed from a biomarker testing and treatment perspective
Discuss anticipated ongoing impacts to patient care over the next year
Discuss how best to normalize and ensure access to testing and treatment are maintained

Host: Anna Plotkin, OAP President

Target audience: Pathologists, Resident, Medical Student, Pathologists’ Assistants

CanMEDS Role:Medical Expert, Communicator, Collaborator, Leader, Professional>

This event is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada and approved by the CAP-ACP. You may claim a maximum of 1.0 hours per event attended. (credits are automatically calculated).

This webinar is co-developed with EMD Serono, Pfizer and OAP was planned to achieve scientific integrity, objectivity and balance.

The physician organization (OAP) has ultimate authority over all decisions and is accountable to ensure that the administrative, educational and ethical accreditation standards for group learning activities are met.

Managing Biomarker Testing in NSCLC Patients